MM24-01a

Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: A CIBMTR study.

Citation

Hansen DK, Dima D, Mian H, Devos J, Brazauskas R, Oloyede T, Afrough A, Ahmed N, Anderson L, Banerjee R, Berdeja JG, Bidikian A, Dhakal B, Dias A, Efebera Y, Faisal MS, Gowda L, Hashmi H, Mirza AS, Mohan M, Narra R, Rosko AE, Schroeder M, Nishihori T, Landau H, Usmani S, Pasquini MC, Akhtar OS, Sidana S, Patel KK.

Blood Cancer Journal. 2026, Apr 14: (): . doi: 10.1038/s41408-026-01496-w. Epub 2026, Apr 14. PMCID:.

PubMed

PMID: 41980929

Abstract